A meta-analysis of 6 studies 13,20,30,32,33,35 which attempted to estimate overall effect size of the changes from baseline in % FMD following GLP-1-based therapies could not find any significant difference between baseline and end-of-treatment samples (mean change from baseline was 0.83 [1.06, 2.73] %
At the highest dose of 12 mg, participants with type 2 diabetes achieved a mean body weight reduction of approximately 16.9% from baseline at 24 weeks
Adjustments & Maintenance Peptide therapy is highly adaptable
December 14, 2025
However, a key limitation of most of these studies that reported no association is their small sample sizes and the lack of longitudinal sampling necessary to capture transient viral infections
It is the primary culprit behind the feelings we associate with a hangover, such as nausea, headaches, and fatigue